108 filings
Page 4 of 6
CORRESP
fj3l 2x38cbs
15 Dec 21
Correspondence with SEC
12:00am
D
ql4cjvo
3 Dec 21
$12.82M in equity / options / securities to be acquired, sold $3.54M, 12 investors
4:16pm
8-K
dv59a4dlue av
1 Dec 21
Petros Pharmaceuticals Announces $10 Million Offering
5:12pm
424B5
2mvoextxc
1 Dec 21
Prospectus supplement for primary offering
5:10pm
EFFECT
xat3lpb
24 Nov 21
Notice of effectiveness
12:15am
424B3
zohtp1oefyq6mg
23 Nov 21
Prospectus supplement
4:11pm
CORRESP
wn1unv1rdc0vfagho5w8
23 Nov 21
Correspondence with SEC
12:00am
DEF 14A
cwt3 qf3aadva4n7d
22 Nov 21
Definitive proxy
4:37pm
CORRESP
j8f grtrbxk
22 Nov 21
Correspondence with SEC
12:00am
UPLOAD
xo4zxz
19 Nov 21
Letter from SEC
12:00am
8-K
org1y2k0fj9do6c
17 Nov 21
Shareholder Nominations Pursuant to Exchange Act Rule 14a-11
5:20pm
8-K
hp4qnx2taisf7ua
16 Nov 21
Petros Pharmaceuticals Reports Third Quarter Financial Results and Provides Corporate Update
12:00am
S-1
rro91t1jh3oy47cj
12 Nov 21
IPO registration
5:03pm
D
cyv480th096gz
26 Oct 21
$5.92M in options / securities to be acquired, 10 investors
1:39pm
8-K
hgv5uhutps820pw
15 Oct 21
Petros Pharmaceuticals Announces $5.7 Million Registered Direct Offering
5:03pm
424B5
r4skws
15 Oct 21
Prospectus supplement for primary offering
5:01pm
10-Q
cw2s y6a6lq
14 May 21
Quarterly report
4:31pm